TPIDB > Principal Investigator
Principal Investigator
National Taiwan University Hospital
(在職)
Division of General Internal Medicine
Division of Hematology & Oncology
Division of Thoracic Medicine
Division of Infectious Disease
National Taiwan University Hospital Hsin-Chu Branch
(在職)
Division of Thoracic Medicine
Division of General Internal Medicine
National Taiwan University Cancer Center
Division of General Internal Medicine
更新時間:2025-03-04
余忠仁Yu, Chong-Jen
- Principal Investigator
- Clinical Trial Experience (year) 23 years 9 個月
Publication
116Publications
61
Chien JY, Lin CK, Yu CJ, Hsueh PR. Usefulness of Xpert MTB/RIF Ultra to Rapidly Diagnose Sputum Smear-Negative Pulmonary Tuberculosis Using Bronchial Washing Fluid. Front Microbiol. 2020 Sep 22;11:588963. doi: 10.3389/fmicb.2020.588963. PMID: 33072058; PMCID: PMC7536285.
62
Chen PY, Yu CJ, Chien JY, Hsueh PR. Anidulafungin as an alternative treatment for Pneumocystis jirovecii pneumonia in patients who cannot tolerate trimethoprim/sulfamethoxazole. Int J Antimicrob Agents. 2020 Jan;55(1):105820. doi: 10.1016/j.ijantimicag.2019.10.001. Epub 2019 Oct 14. PMID: 31622654.
63
Chang CL, Chen LC, Yu CJ, Hsueh PR, Chien JY. Different clinical features of patients with pulmonary disease caused by various Mycobacterium avium-intracellulare complex subspecies and antimicrobial susceptibility. Int J Infect Dis. 2020 Sep;98:33-40. doi: 10.1016/j.ijid.2020.06.019. Epub 2020 Jun 10. PMID: 32534139.
64
Wong JYY, Zhang H, Hsiung CA, Shiraishi K, Yu K, Matsuo K, Wong MP, Hong YC, Wang J, Seow WJ, Wang Z, Song M, Kim HN, Chang IS, Chatterjee N, Hu W, Wu C, Mitsudomi T, Zheng W, Kim JH, Seow A, Caporaso NE, Shin MH, Chung LP, An SJ, Wang P, Yang Y, Zheng H, Yatabe Y, Zhang XC, Kim YT, Cai Q, Yin Z, Kim YC, Bassig BA, Chang J, Ho JCM, Ji BT, Daigo Y, Ito H, Momozawa Y, Ashikawa K, Kamatani Y, Honda T, Hosgood HD, Sakamoto H, Kunitoh H, Tsuta K, Watanabe SI, Kubo M, Miyagi Y, Nakayama H, Matsumoto S, Tsuboi M, Goto K, Shi J, Song L, Hua X, Takahashi A, Goto A, Minamiya Y, Shimizu K, Tanaka K, Wei F, Matsuda F, Su J, Kim YH, Oh IJ, Song F, Su WC, Chen YM, Chang GC, Chen KY, Huang MS, Chien LH, Xiang YB, Park JY, Kweon SS, Chen CJ, Lee KM, Blechter B, Li H, Gao YT, Qian B, Lu D, Liu J, Jeon HS, Hsiao CF, Sung JS, Tsai YH, Jung YJ, Guo H, Hu Z, Wang WC, Chung CC, Burdett L, Yeager M, Hutchinson A, Berndt SI, Wu W, Pang H, Li Y, Choi JE, Park KH, Sung SW, Liu L, Kang CH, Zhu M, Chen CH, Yang TY, Xu J, Guan P, Tan W, Wang CL, Hsin M, Sit KY, Ho J, Chen Y, Choi YY, Hung JY, Kim JS, Yoon HI, Lin CC, Park IK, Xu P, Wang Y, He Q, Perng RP, Chen CY, Vermeulen R, Wu J, Lim WY, Chen KC, Li YJ, Li J, Chen H, Yu CJ, Jin L, Chen TY, Jiang SS, Liu J, Yamaji T, Hicks B, Wyatt K, Li SA, Dai J, Ma H, Jin G, Song B, Wang Z, Cheng S, Li X, Ren Y, Cui P, Iwasaki M, Shimazu T, Tsugane S, Zhu J, Chen Y, Yang K, Jiang G, Fei K, Wu G, Lin HC, Chen HL, Fang YH, Tsai FY, Hsieh WS, Yu J, Stevens VL, Laird-Offringa IA, Marconett CN, Rieswijk L, Chao A, Yang PC, Shu XO, Wu T, Wu YL, Lin D, Chen K, Zhou B, Huang YC, Kohno T, Shen H, Chanock SJ, Rothman N, Lan Q. Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women. Genomics. 2020 Mar;112(2):1223-1232. doi: 10.1016/j.ygeno.2019.07.008. Epub 2019 Jul 12. PMID: 31306748; PMCID: PMC6954985.
65
Wang PH, Pan SW, Shu CC, Chen CY, Wei YF, Cheng SL, Wang HC, Yu CJ. Clinical course and risk factors of mortality in Mycobacterium avium complex lung disease without initial treatment. Respir Med. 2020 Sep;171:106070. doi: 10.1016/j.rmed.2020.106070. Epub 2020 Jun 25. PMID: 32658834.
66
Shu CC, Wei YF, Yeh YC, Lin HH, Chen CY, Wang PH, Cheng SL, Wang JY, Yu CJ. The impact on incident tuberculosis by kidney function impairment status: analysis of severity relationship. Respir Res. 2020 Feb 12;21(1):51. doi: 10.1186/s12931-020-1294-5. PMID: 32050967; PMCID: PMC7017479.
67
Chen SY, Huang CK, Peng HC, Yu CJ, Chien JY. Inappropriate Peak Inspiratory Flow Rate with Dry Powder Inhaler in Chronic Obstructive Pulmonary Disease. Sci Rep. 2020 Apr 29;10(1):7271. doi: 10.1038/s41598-020-64235-6. PMID: 32350352; PMCID: PMC7190738.
68
Chen SY, Huang CK, Peng HC, Yu CJ, Chien JY. Inappropriate Peak Inspiratory Flow Rate with Dry Powder Inhaler in Chronic Obstructive Pulmonary Disease. Sci Rep. 2020 Apr 29;10(1):7271. doi: 10.1038/s41598-020-64235-6. PMID: 32350352; PMCID: PMC7190738.
69
Huang TM, Kuo KC, Wang YH, Wang CY, Lai CC, Wang HC, Chen L, Yu CJ; On the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE). Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids. BMC Infect Dis. 2020 Sep 25;20(1):706. doi: 10.1186/s12879-020-05440-6. PMID: 32977747; PMCID: PMC7519522.
70
Huang CT, Hong CM, Tsai YJ, Sheng WH, Yu CJ. Gastrointestinal complications are associated with a poor outcome in non-critically ill pneumonia patients. BMC Gastroenterol. 2020 Nov 16;20(1):383. doi: 10.1186/s12876-020-01537-z. PMID: 33198635; PMCID: PMC7670594.